Thank you very much.
This is a fairly long amendment. I won't read out it in the interests of time. I hope committee members have had an opportunity to read it.
Basically, this would add a new section or clause empowering Health Canada to publish positive and negative regulatory decisions. We think that at a minimum Health Canada should publish rationales for decisions concerning drugs that were approved for sale, drugs refused for reasons of safety or efficacy, and drugs that are suspended or recalled. It's a new section. I think there have been other similar government amendments, but I think this adds more clarity and better definition to the regulations.